Attentional window in schizophrenia and schizotypal personality: Insight from negative priming studies

Applied & Preventive Psychology : Journal of the American Association of Applied and Preventive Psychology
Randall K Minas, Sohee Park

Abstract

One of the core deficits that characterizes schizophrenia is an increase in distractibility and disinhibition at all levels of information processing. Patients with schizophrenia seem unable to focus attention on the relevant events while ignoring the irrelevant stimuli. This pattern of behavior is also observed in unmedicated schizotypal individuals who may carry liability for schizophrenia. In this review, we focus on studies of attentional inhibition, as assessed by the negative priming paradigm, to elucidate the relationships among deficits in inhibition, clinical symptoms and medication effects. We then consider models of the etiology of deficits in negative priming in schizophrenia and schizotypal personality. Finally, we discuss the potential power of utilizing hypothesis-driven cognitive paradigms in psychiatric research.

References

Nov 1, 1992·Biological Psychiatry·S H JonesD R Hemsley
Sep 1, 1992·The British Journal of Clinical Psychology·L LaplanteJ Thomas
Mar 1, 1992·Archives of General Psychiatry·D L BraffM A Geyer
May 1, 1989·The British Journal of Clinical Psychology·A BeechG Claridge
Oct 1, 1988·The Journal of Nervous and Mental Disease·I BaruchJ A Gray
Jan 1, 1988·Schizophrenia Research·T C ManschreckM L Schneyer
Aug 1, 1987·British Journal of Psychology·A Beech, G Claridge
Jan 1, 1985·Schizophrenia Bulletin·B A CornblattL Erlenmeyer-Kimling
Nov 1, 1985·The Quarterly Journal of Experimental Psychology. A, Human Experimental Psychology·S P Tipper
Jan 1, 1980·Schizophrenia Bulletin·L J ChapmanJ P Chapman
Jul 1, 1995·Psychological Bulletin·C P MayL Hasher
May 1, 1995·The Journal of Nervous and Mental Disease·A S David
Feb 1, 1994·The British Journal of Clinical Psychology·E R PetersD R Hemsley
Jan 1, 1993·Schizophrenia Bulletin·J M McDowdD L Braff
Nov 14, 1997·Journal of Abnormal Psychology·R SaloL W Kraft
Sep 29, 2000·The Journal of Nervous and Mental Disease·S MoritzB Andresen
Apr 11, 2001·Schizophrenia Research·L A JonesJ Williams
Apr 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·Peter J Siekmeier, Ralph E Hoffman
Jan 23, 2003·Psychological Medicine·G M MacQueenS P Tipper
Jan 1, 1962·Archives of General Psychiatry·D SHAKOW
Sep 23, 2003·Journal of Personality and Social Psychology·Shelley H CarsonDaniel M Higgins
Jun 28, 2005·Schizophrenia Research·M VinkR S Kahn
May 26, 2006·Journal of Clinical and Experimental Neuropsychology·Mark ZimmermannDieter Vaitl
Jan 1, 1992·Journal of Psychopharmacology·C D Frith

❮ Previous
Next ❯

Citations

Dec 4, 2008·Applied & Preventive Psychology : Journal of the American Association of Applied and Preventive Psychology·Daniel G Dillon, Diego A Pizzagalli
Apr 29, 2015·Psychonomic Bulletin & Review·Christian FringsElaine Fox
Mar 27, 2015·Schizophrenia Bulletin·Ulrich EttingerSohee Park
Dec 27, 2018·PloS One·Antoinette Sabatino DiCriscioVanessa Troiani
Aug 20, 2017·Experimental Brain Research·Zachary Yaple, Marie Arsalidou

❮ Previous
Next ❯

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here